| The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology J Wienke, MP Dierselhuis, GAM Tytgat, A Künkele, S Nierkens, ... European journal of cancer 144, 123-150, 2021 | 168 | 2021 |
| Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome LL van den Hoogen, JAG van Roon, JS Mertens, J Wienke, AP Lopes, ... Annals of the rheumatic diseases 77 (12), 1810-1814, 2018 | 84 | 2018 |
| Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools J Wienke, CT Deakin, LR Wedderburn, F van Wijk, A van Royen-Kerkhof Frontiers in Immunology 9, 2951, 2018 | 76 | 2018 |
| Galectin‐9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation J Wienke, F Bellutti Enders, J Lim, JS Mertens, LL van den Hoogen, ... Arthritis & Rheumatology 71 (8), 1377-1390, 2019 | 72 | 2019 |
| A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation J Wienke, W Janssen, R Scholman, H Spits, M van Gijn, M Boes, ... Oncotarget 6 (24), 20037, 2015 | 44 | 2015 |
| Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response B Lerkvaleekul, SR Veldkamp, MM Van Der Wal, EJH Schatorje, ... Rheumatology 61 (5), 2144-2155, 2022 | 37 | 2022 |
| Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy J Wienke, LL Visser, WM Kholosy, KM Keller, M Barisa, E Poon, ... Cancer Cell 42 (2), 283-300. e8, 2024 | 34 | 2024 |
| Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent … J Wienke, LM Pachman, GA Morgan, JG Yeo, MC Amoruso, V Hans, ... Arthritis & Rheumatology 72 (7), 1214-1226, 2020 | 33 | 2020 |
| Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs J Wienke, L Brouwers, LM van der Burg, M Mokry, RC Scholman, ... JCI insight 5 (18), e137926, 2020 | 31 | 2020 |
| Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch AM Cornel, E Dunnebach, DA Hofman, S Das, S Sengupta, ... Journal for Immunotherapy of Cancer 10 (12), e005002, 2022 | 27 | 2022 |
| Neuroblastoma and DIPG organoid coculture system for personalized assessment of novel anticancer immunotherapies W M. Kholosy, M Derieppe, F van den Ham, K Ober, Y Su, L Custers, ... Journal of personalized medicine 11 (9), 869, 2021 | 26 | 2021 |
| Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk J Wienke, JS Mertens, S Garcia, J Lim, CA Wijngaarde, JG Yeo, A Meyer, ... Rheumatology 60 (2), 785-801, 2021 | 26 | 2021 |
| The identification of CCL18 as biomarker of disease activity in localized scleroderma JS Mertens, E de Jong, LL van Den Hoogen, J Wienke, RM Thurlings, ... Journal of Autoimmunity 101, 86-93, 2019 | 25 | 2019 |
| Juvenile dermatomyositis and the inflammatory myopathies C Swafford, ES Roach Seminars in Neurology 40 (03), 342-348, 2020 | 19 | 2020 |
| T cell interaction with activated endothelial cells primes for tissue-residency J Wienke, SR Veldkamp, EM Struijf, FA Yousef Yengej, MM van der Wal, ... Frontiers in immunology 13, 827786, 2022 | 17 | 2022 |
| Regarding “transcriptional and cytokine profiles identify CXCL9 as a biomarker of disease activity in morphea” JS Mertens, E de Jong, A Pandit, MMB Seyger, E Hoppenreijs, ... Journal of Investigative Dermatology 138 (5), 1212-1215, 2018 | 16 | 2018 |
| αβ-T cells engineered to express γδ-T cell receptors can kill neuroblastoma organoids independent of MHC-I expression JGM Strijker, R Pscheid, E Drent, JJF van der Hoek, B Koopmans, K Ober, ... Journal of Personalized Medicine 11 (9), 923, 2021 | 11 | 2021 |
| Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis KJ Blom, T Takken, BCH Huijgen, J Wienke, A van Royen-Kerkhof, ... Rheumatology 56 (12), 2204-2211, 2017 | 9 | 2017 |
| Endothelial and inflammatory biomarker profile at diagnosis reflects clinical heterogeneity of juvenile dermatomyositis and is prognostic for response to treatment in two … J Wienke, LM Pachman, GA Morgan, JG Yeo, MC Amoruso, V Hans, ... Arthritis & rheumatology (Hoboken, NJ) 72 (7), 1214, 2020 | 6 | 2020 |
| Anti–cytosolic 5′‐nucleotidase 1A autoantibodies are absent in juvenile dermatomyositis A Rietveld, J Wienke, E Visser, W Vree Egberts, W Schlumberger, ... Arthritis & Rheumatology 73 (7), 1329-1333, 2021 | 5 | 2021 |
